NO991013D0 - Krystallinsk farmas°ytisk produkt - Google Patents

Krystallinsk farmas°ytisk produkt

Info

Publication number
NO991013D0
NO991013D0 NO991013A NO991013A NO991013D0 NO 991013 D0 NO991013 D0 NO 991013D0 NO 991013 A NO991013 A NO 991013A NO 991013 A NO991013 A NO 991013A NO 991013 D0 NO991013 D0 NO 991013D0
Authority
NO
Norway
Prior art keywords
pharmaceutical product
crystalline pharmaceutical
crystalline
product
pharmaceutical
Prior art date
Application number
NO991013A
Other languages
English (en)
Norwegian (no)
Other versions
NO991013L (no
Inventor
Stephen Torey Ross
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO991013L publication Critical patent/NO991013L/no
Publication of NO991013D0 publication Critical patent/NO991013D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO991013A 1996-09-03 1999-03-02 Krystallinsk farmas°ytisk produkt NO991013D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2536996P 1996-09-03 1996-09-03
PCT/US1997/015292 WO1998009629A1 (fr) 1996-09-03 1997-08-29 Produit pharmaceutique cristallin

Publications (2)

Publication Number Publication Date
NO991013L NO991013L (no) 1999-03-02
NO991013D0 true NO991013D0 (no) 1999-03-02

Family

ID=21825633

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991013A NO991013D0 (no) 1996-09-03 1999-03-02 Krystallinsk farmas°ytisk produkt

Country Status (32)

Country Link
US (1) US6335330B1 (fr)
EP (1) EP0964684B1 (fr)
JP (1) JP2000517342A (fr)
CN (1) CN1102391C (fr)
AP (1) AP9901472A0 (fr)
AR (1) AR008154A1 (fr)
AT (1) ATE245984T1 (fr)
AU (1) AU731173B2 (fr)
BG (1) BG103196A (fr)
BR (1) BR9711981A (fr)
CA (1) CA2264607A1 (fr)
CO (1) CO4930262A1 (fr)
CZ (1) CZ71999A3 (fr)
DE (1) DE69723873T2 (fr)
DZ (1) DZ2302A1 (fr)
EA (1) EA001363B1 (fr)
ES (1) ES2205254T3 (fr)
HU (1) HUP9904077A3 (fr)
ID (1) ID18156A (fr)
IL (1) IL128782A0 (fr)
MA (1) MA24309A1 (fr)
MY (1) MY118175A (fr)
NO (1) NO991013D0 (fr)
NZ (1) NZ334438A (fr)
OA (1) OA10986A (fr)
PE (1) PE107198A1 (fr)
PL (1) PL332006A1 (fr)
SK (1) SK27699A3 (fr)
TR (1) TR199900480T2 (fr)
UY (1) UY24690A1 (fr)
WO (1) WO1998009629A1 (fr)
ZA (1) ZA977870B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19902529A1 (de) * 1999-01-22 2000-08-03 Goldwell Gmbh Haarbehandlungsmittel
FR2797400A1 (fr) * 1999-08-11 2001-02-16 Sanofi Synthelabo Associations a activite anti-thrombotique constituees de l'hydrogenosulfate de clopidogrel et d'un antagoniste des recepteurs gpiib/iiia et les compositions pharmaceutiques les contenant
WO2003059251A2 (fr) 2001-10-22 2003-07-24 The Scripps Research Institute Composes de ciblage d'anticorps
US20050202151A1 (en) * 2004-03-15 2005-09-15 Land O'lakes, Inc. Method of preparing egg nuggets
KR101046977B1 (ko) * 2004-11-15 2011-07-07 삼성에스디아이 주식회사 카본나노튜브, 이를 포함한 전자 방출원 및 이를 구비한전자 방출 소자
WO2007048127A2 (fr) * 2005-10-20 2007-04-26 The Scripps Research Institute MARQUAGE DE PARTIES Fc POUR L'IMMUNOCOLORATION ET L'IMMUNOCIBLAGE
WO2010093706A2 (fr) 2009-02-10 2010-08-19 The Scripps Research Institute Vaccination programmée chimiquement

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD138319A1 (de) * 1978-08-08 1979-10-24 Helmut Roehnert Verfahren zur herstellung einer stabilen,kristallwasser-und kristalloesungsmittelfreien kristallform des 7-chlor-2-methylamino-5-phenyl-3h-1,4-benzodiazepin-4-oxid-hydrochlorids
US5939412A (en) 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
AU666318B2 (en) 1991-06-28 1996-02-08 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
SG63579A1 (en) 1992-12-21 1999-03-30 Smithkline Beecham Corp Bicyclic fibrinogen antagonists
MA23420A1 (fr) 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.

Also Published As

Publication number Publication date
CZ71999A3 (cs) 1999-08-11
HUP9904077A3 (en) 2002-03-28
DZ2302A1 (fr) 2002-12-28
ES2205254T3 (es) 2004-05-01
AU4242597A (en) 1998-03-26
ID18156A (id) 1998-03-05
NO991013L (no) 1999-03-02
ZA977870B (en) 1998-03-03
NZ334438A (en) 2000-10-27
MY118175A (en) 2004-09-30
DE69723873D1 (de) 2003-09-04
BG103196A (en) 1999-09-30
AP9901472A0 (en) 1999-03-31
IL128782A0 (en) 2000-01-31
CN1234739A (zh) 1999-11-10
EA001363B1 (ru) 2001-02-26
CO4930262A1 (es) 2000-06-27
AR008154A1 (es) 1999-12-09
CA2264607A1 (fr) 1998-03-12
BR9711981A (pt) 1999-08-24
PE107198A1 (es) 1999-03-21
US6335330B1 (en) 2002-01-01
HUP9904077A2 (hu) 2000-05-28
UY24690A1 (es) 1998-02-27
JP2000517342A (ja) 2000-12-26
PL332006A1 (en) 1999-08-16
ATE245984T1 (de) 2003-08-15
EP0964684A1 (fr) 1999-12-22
WO1998009629A1 (fr) 1998-03-12
CN1102391C (zh) 2003-03-05
EP0964684A4 (fr) 2002-05-29
MA24309A1 (fr) 1998-04-01
TR199900480T2 (xx) 1999-06-21
EA199900260A1 (ru) 1999-08-26
EP0964684B1 (fr) 2003-07-30
AU731173B2 (en) 2001-03-22
OA10986A (en) 2003-03-04
SK27699A3 (en) 2000-02-14
DE69723873T2 (de) 2004-04-22

Similar Documents

Publication Publication Date Title
NO953657L (no) Nytt farmasöytisk produkt
DE69903605D1 (de) Verpacktes produkt
DE69602606D1 (de) Verkapseltes produkt
DE69426294D1 (de) Rehydrierbares produkt
DE69629671D1 (de) Netzbares produkt
BR9610214A (pt) Compostos farmacéuticos
DE69830304D1 (de) Gefrierschutzpeptide enthaltendes gefrorenes produkt
EE9900260A (et) Ravimkompositsioonid külmkuivatamiseks
NO992724D0 (no) Farmas°ytiske blandinger inneholdende N-sulfonyl-indolin-derivater
NO991013L (no) Krystallinsk farmas°ytisk produkt
DE59807753D1 (de) Schellackhaltiges kosmetisches produkt
NO975436D0 (no) Laminært produkt
DK0864255T3 (da) Vandkontinuerligt smørbart produkt
PT850048E (pt) Granulos farmaceuticos
NO965448L (no) Farmasöytiske forbindelser
ATA173599A (de) Pharmazeutisches produkt
FI102809B1 (fi) Lääkesäiliö
DE69819203D1 (de) Trinkbares arzneimittel
UA1090S (uk) Фармацевтичний виріб
UA1246S (uk) Таблетка фармацевтична
DK128993D0 (da) Laegemiddel/-plante
DK139993D0 (da) Produkt
DK140093D0 (da) Produkt
DK0850048T3 (da) Farmaceutiske granulae
FI3575U1 (fi) Sidontatuote

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application